Brazilian pediatricians warn of vaccine misinformation and vaping risks to youth

Youth exposed to vaping-related respiratory damage, chronic cough, and reduced physical performance; vaccine hesitancy increases disease vulnerability in children.
When algorithms amplify doubt faster than facts can travel
On how misinformation about vaccines spreads through social media and erodes public trust in immunization programs.

Fifty years after launching one of the world's most successful immunization programs, Brazil now faces the quiet unraveling of the public trust that made it possible. Pediatric specialists gathered to name two forces working against the health of the country's children: the spread of vaccine misinformation through social media, and the calculated marketing of e-cigarettes to young people. These are not isolated crises but symptoms of a deeper vulnerability — what happens when institutional authority erodes and commercial interests move faster than regulation. The Brazilian Pediatric Society is asking whether trusted medical voices, speaking plainly and publicly, can still turn the tide.

  • Measles has returned to Brazil after near-elimination, a visible sign that declining vaccination coverage is already costing children their protection.
  • Misinformation travels through social media algorithms faster than facts, and the pandemic accelerated a collapse in public trust that took decades to build.
  • E-cigarettes engineered with high nicotine concentrations are reaching Brazilian youth through attractive designs, causing bronchitis, chronic cough, and measurable damage to young athletes' aerobic capacity.
  • Brazil banned heated tobacco products in 2009 and reaffirmed that ban in 2024, yet the legal framework has not stopped the industry from finding new pathways to children.
  • The Brazilian Pediatric Society is broadcasting free public discussions to place credible medical voices back into the spaces where doubt and commercial messaging have taken hold.

Brazil's pediatric community is raising an alarm about two simultaneous threats to children's health: collapsing vaccine confidence and the aggressive spread of e-cigarettes among youth. The warning was delivered through PedTalks, a public discussion series run by the Brazilian Pediatric Society, with pulmonologist Dr. Margareth Dalcolmo offering a clear-eyed account of what is at stake.

The occasion carried a bittersweet quality. Brazil's National Immunization Program recently turned fifty, and its record is remarkable — life expectancy has climbed from fifty-four to seventy-eight years, and childhood mortality has fallen dramatically. But that legacy is now under pressure. Vaccination coverage has dropped since the pandemic, and measles, once nearly eradicated, has come back. Dalcolmo and her colleagues identified social media misinformation as a central cause, noting that the problem is less about ignorance than about the collapse of institutional trust itself. The pandemic also exposed Brazil's dependence on foreign suppliers for vaccines and medicines, a vulnerability that demands both policy reform and a sustained effort to rebuild public confidence.

The second crisis involves e-cigarettes, which have spread rapidly among Brazilian youth through deliberate industry tactics — appealing designs, high nicotine concentrations, and normalization before regulation can respond. The health consequences are concrete: bronchitis, chronic cough, reduced aerobic performance, and exposure to carcinogenic substances. Disposable devices are also appearing on beaches and in public spaces, adding an environmental dimension to the damage.

Brazil has a strong record on tobacco control, having banned heated tobacco products in 2009 and reaffirmed that commitment in 2024. But legal frameworks alone have not kept the industry away from children. The pediatric community is responding by taking its case directly to the public through free broadcasts, trying to reclaim the conversation from misinformation and commercial pressure. Whether that effort will prove sufficient remains uncertain.

Brazil's pediatric establishment is sounding an alarm about two converging threats to the health of the country's children: the erosion of trust in vaccines and the aggressive marketing of e-cigarettes to young people. The warning came during a recent episode of PedTalks, a public discussion series run by the Brazilian Pediatric Society, where Dr. Margareth Dalcolmo, a pulmonologist and member of Brazil's National Academy of Medicine, laid out the stakes with clinical precision.

The conversation began with a milestone worth celebrating. Brazil's National Immunization Program turned fifty this year, and the numbers tell a story of public health triumph. Since its inception, the program has helped raise life expectancy in Brazil from fifty-four to seventy-eight years. Childhood mortality has plummeted. These are not abstract achievements—they represent millions of children who lived to adulthood because of vaccines. Yet that success is now under threat. Vaccination coverage has declined, a trend that accelerated during the pandemic. The consequences are already visible: measles, a disease that had been nearly eliminated, has returned.

Dalcolmo and her colleagues traced much of this decline to misinformation spreading across social media. The problem is not ignorance alone but the erosion of authority itself. When people no longer trust the voices telling them vaccines are safe, when algorithms amplify doubt faster than facts can travel, entire communities can slip backward into vulnerability. The pandemic exposed another fragility: Brazil's dependence on foreign suppliers for vaccines and medicines. When the world locked down, the country found itself without the domestic capacity to produce what it needed. That vulnerability, Dalcolmo emphasized, demands not just better policy but a deliberate effort to rebuild public confidence through trustworthy voices.

The second crisis is more recent but no less urgent. E-cigarettes have become ubiquitous among Brazilian youth, and the industry marketing them has been ruthless. The devices come in attractive designs and contain nicotine concentrations far higher than traditional cigarettes. They are, in effect, engineered to addict. The health consequences are immediate and concrete. Vaping causes bronchitis and chronic cough. It damages aerobic capacity in young athletes. The devices contain carcinogenic substances. Beyond the respiratory damage, there is an environmental cost: disposable vapes are contaminating beaches and public spaces.

Brazil has a history of standing firm on tobacco control. In 2009, the country became a pioneer by banning the manufacture, sale, and advertising of heated tobacco products—a regulation that was reaffirmed in 2024. Yet that legal framework has not stopped the e-cigarette industry from finding ways to reach children. The industry's strategy is deliberate: make the product appealing, make it addictive, and normalize it before regulation can catch up.

What emerges from this discussion is a picture of institutional vulnerability meeting coordinated commercial pressure. Vaccine confidence, once taken for granted, now requires active defense. The pediatric community understands that they cannot win this battle alone. They need media literacy, they need regulation, and they need the public to understand that the stakes are their children's lives. The PedTalks series, broadcast free on the Brazilian Pediatric Society's website and YouTube channel, is one attempt to reclaim that space—to put trusted medical voices back into the conversation where misinformation has gained ground. Whether it will be enough remains an open question.

The pandemic exposed Brazil's vulnerability through dependence on foreign suppliers for vaccines and medicines, demanding efforts to rebuild public confidence through trustworthy voices
— Dr. Margareth Dalcolmo, pulmonologist and member of Brazil's National Academy of Medicine
E-cigarettes cause bronchitis, chronic cough, and damage aerobic capacity in young people, with immediate and concrete health consequences
— Dr. Margareth Dalcolmo
La Conversación del Hearth Otra perspectiva de la historia
Inventor

Why does vaccine confidence matter so much right now? Measles was nearly gone.

Model

Because immunity is only as strong as the weakest link. When coverage drops below a certain threshold, the virus finds its way back in. We saw it happen. The pandemic didn't just disrupt vaccination schedules—it broke something deeper: the assumption that these programs were settled science.

Inventor

And the misinformation—is it coming from a particular source, or is it just noise everywhere?

Model

It's not organized the way people sometimes imagine. It's more that social media rewards outrage and doubt. A parent sees a scary post, shares it, and suddenly it's in a hundred feeds. Meanwhile, the actual evidence moves slowly. We can't compete with that speed.

Inventor

Let's talk about vaping. Why are e-cigarettes so much more dangerous than we initially thought?

Model

Because we underestimated the nicotine concentration. These aren't harm-reduction devices—they're delivery systems designed to create dependency in adolescents whose brains are still developing. The bronchitis and chronic cough are just the beginning.

Inventor

Brazil banned heated tobacco products back in 2009. Why didn't that stop e-cigarettes?

Model

Because the industry is always one step ahead. They found a loophole or created a new product category. Regulation is reactive. By the time you ban one thing, they're already marketing the next.

Inventor

What would actually move the needle on vaccine confidence?

Model

Pediatricians in clinics, talking to parents face-to-face. Teachers. Community leaders. People who have earned trust over time. Not a campaign. A presence. Showing up and answering questions, even the hard ones.

Inventor

And for vaping?

Model

Regulation that actually sticks, and honesty about what these devices do. But also—we need to ask why young people are drawn to them in the first place. What are they looking for? That's the conversation we're not having.

Contáctanos FAQ